Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think tomorrow will be the day. Civil war starts tomorrow, maybe?
Out of curiosity, why aren’t you putting it up in smaller blocks?
I see.
Someone hit the ask for 1.6m shares at .015, now 2.2m has been on the bid at .016 for about 2 hours.
Wow moving today. Just noticed.
You inspired me to change my name too.
I disagree
Nice name change.
https://www.newsweek.com/40-las-front-line-workers-declined-covid-vaccine-some-county-icus-run-out-beds-1558318
“40% of LA's Front-Line Workers Declined COVID Vaccine as Some County ICU's Run Out of Beds”
I could care less.
“Up until now I had not been too concerned”, which suggests that you are now concerned.
“I believe the timing is right where it no longer hurts the company”, which suggests that you are no longer concerned.
Which one did you mean?
Lol, nothing I guess.
What makes you so concerned now all of a sudden?
I haven’t talked to any lawyer yet. I’ll wait until the annual report. If nothing changes, then I’ll contact a lawyer. Not too worried about it right now.
If you care that Ronny B is involved with the company, I’ve got some news for you - you’ve known for years, and you never cared until now.
You’re the one with a screen name Ronny B, and you’re asking me? Go ask Ronny B.
Who cares?
What
Ron Brouliette, not sure the spelling.
Funny that Ronny B asks about Relaunch Consulting, when the owner of Relaunch Consulting is also Ronny B.
Nice to see this moving.
“Phase 2 covid starting 12/20”
Does not look like it. On the conference call, they said they were hoping to start in December, but it does not look like that’s happening.
Market makers can and do move / manipulate every ticker. SPY, AAPL, doesn’t matter. They move every ticker wherever they please.
I would guess that he’s this guy...
https://www.otcmarkets.com/filing/html?id=14240049&guid=iRhqUpiQAePYt3h
He can correct me if I’m wrong. Or not.
EJ23ny
Kind of unbelievable to look at a chart of the volume spike after hours vs regular hours, and more than a day later, not a single person has posted why it spiked.
This is likely what he’s talking about, from Oct 20th.
https://www.google.com/amp/s/seekingalpha.com/amp/news/3623747-immune-therapeutics-surges-on-merger-cytocom-and-cleveland-biolabs
They’re not trying to get people to buy IMO.
Replying to yourself, “talk to you later”. Just wanted to point that out.
I have no idea what he’s talking about.
Huh? BIIB is acquiring CYTO? Where do you see that?
My bad...I made a mistake. This was not a specific recommendation by NIH, as I initially perceived it to be. And that’s what I meant when I was referring to Fauci.
This was over 2 months ago.
No PR from the company about NIH being on board with LDN? Not surprising.
This basically means...Fauci has given LDN the ok.
“based on our data, we proposed FDA-approved LDN can be used in combination or as an adjuvants therapy to treat mild to moderate symptomatic COVID-19 patients.”
And they’re willing to say that without a COVID trial ongoing.
From my understanding, all those crohn’s drugs are toxic. They don’t compare to LDN.
I think Crohn’s is the one with the most potential. That’s my understanding anyway.
Seems to me like they might be fine just with the crohn’s / fibromyalgia / MS phase 3 trials. Is it MS? Or is it pancreatic cancer? Covid would be a bonus, either way.
You’re welcome
They won’t have 15% of the combined company.
Cytocom will have 61% and CBLI will have 39% of the merged company. So at best, IMUN would have 15% of 61% = 9%. There could be extra dilution that leaves us with less, though, I don’t know what’s going to happen.